SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Catharina Svanborg | 45,84 | 73,33 | 2021-06-30 |
| Rolf Karlsson | 6,42 | 3,16 | 2021-09-30 |
| Avanza Pension | 4,10 | 2,02 | 2021-09-30 |
| Jan Zetterberg | 3,24 | 1,60 | 2021-09-30 |
| Ernst Carl Fredrik Herslow | 3,20 | 1,58 | 2021-09-30 |
| Helena Lomberg | 1,49 | 0,74 | 2021-09-30 |
| Nordnet Pensionsförsäkring | 1,43 | 0,70 | 2021-09-30 |
| Swedbank Försäkring | 1,38 | 0,68 | 2021-09-30 |
| Monica Strömberg | 1,11 | 0,55 | 2021-09-30 |
| Daniel Åberg | 0,86 | 0,42 | 2021-09-30 |
2021-11-18 Delårsrapport 2022-Q1
2021-11-24 Årsstämma 2021